Rankings
▼
Calendar
EKSO FY 2024 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena
EKSO
Ekso Bionics Holdings, Inc.
$29M
FY 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$18M
-1.9% YoY
Gross Profit
$10M
53.1% margin
Operating Income
-$10M
-58.4% margin
Net Income
-$11M
-63.2% margin
EPS (Diluted)
$-0.56
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$27M
Total Liabilities
$14M
Stockholders' Equity
$13M
Cash & Equivalents
$6M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$18M
-1.9%
Gross Profit
$10M
$9M
+4.8%
Operating Income
-$10M
-$15M
+30.8%
Net Income
-$11M
-$15M
+25.5%
← Q4 2023
All Quarters
Q1 2024 →